Sustainable transfer of biotechnology to developing countries: Fighting poverty by bringing scientific tools to developing-country partners

Annals of the New York Academy of Sciences

Volumn 1136, Issue , 2008, Pages 358-368

  Coloma, Josefina ^b   Harris, Eva ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

Infectious disease diagnosis; Information and communication technologies; Sustainable science in developing countries; Technology transfer

Indexed keywords

ADOLESCENT PREGNANCY; BIOTECHNOLOGY; COMPUTER SYSTEM; DATA BASE; DEVELOPING COUNTRY; DNA SEQUENCE; ENVIRONMENTAL SUSTAINABILITY; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH CARE SYSTEM; HEALTH CENTER; HEALTH SERVICE; HUMAN; IMMUNIZATION; INFORMATION PROCESSING; INFORMATION SYSTEM; INFORMATION TECHNOLOGY; MATERNAL MORTALITY; NICARAGUA; PRENATAL CARE; PREVENTIVE HEALTH SERVICE; QUALITY CONTROL; REVIEW;

EID: 45549089245     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1425.014     Document Type: Review

References (29)

1. WHO. 1999. Report on Infectious Diseases: Removing Obstacles to Healthy Development. World Health Organization. Geneva.
2. Abbasi, K. 2001. Progress is slow in narrowing the health research divide. BMJ 323:886.
3. WHO. 2006. AIDS Epidemic Update. UN-WHO. Geneva.
4. WHO. 2002. Report on Infectious Diseases: Scaling Up the Response to Infectious Disease, A Way Out of Poverty. World Health Organization. Geneva.
5. Greene, M.F. 2002. What will become of Africa's AIDS orphans? New York Times, December 22, 2002.
6. Harris, E., M. López, J. Arévalo, et al. 1993. Short courses on DNA detection and amplification in Central and South America: the democratization of molecular biology. Biochem. Educ. 21:16 22.
7. Harris, E. 1996. Developing essential scientific capability in countries with limited resources. Nat. Med. 2:737 739.
8. Harris, E., A. Belli & N. Agabian. 1996. Appropriate transfer of molecular technology to Latin America for public health and biomedical sciences. Biochem. Educ. 24:3 12.
9. Harris, E. & M. Tanner. 2000. Health technology transfer. BMJ 321:817 820.
10. Harris, E. 1998. A Low-Cost Approach to PCR: Appropriate Transfer of Biomolecular Techniques. Oxford University Press. New York.
11. Coloma, M.J. & E. Harris. 2004. Innovative low cost technologies for biomedical research and diagnosis in developing countries. BMJ 329:1160 1162.
12. Belli, A., B. Rodriguez, H. Avilés & E. Harris. 1998. Simplified PCR detection of New World Leishmania from clinical specimens. Am. J. Trop. Med. Hyg. 58:102 109.
13. Harris, E., G. Kropp, A. Belli, et al. 1998. Single-step multiplex PCR assay for characterization of New World Leishmania complexes. J. Clin. Microbiol. 36:1989 1995.
14. Belli, A., D. Garcia, X. Palacios, et al. 1999. Leishmania chagasi causes widespread atypical cutaneous leishmaniasis in Nicaragua. Am. J. Trop. Med. Hyg. 61:380 385.
15. Gibbons, R.V. & D.W. Vaughn. 2002. Dengue: an escalating problem. BMJ 324:1563 1566.
16. Harris, E., T.G. Roberts, L. Smith, et al. 1998. Typing of dengue viruses in clinical specimens and mosquitoes by single-tube multiplex reverse transcriptase PCR. J. Clin. Microbiol. 36:2634 2639.
17. Harris, E., E. Sandoval, A.M. Xet-Mull, et al. 1999. Rapid subtyping of dengue viruses by restriction site-specific (RSS)-PCR. Virology 253:86 95.
18. Balmaseda, A., M.G. Guzman, S. Hammond, et al. 2003. Diagnosis of dengue virus infection by detection of specific immunoglobulin M (IgM) and IgA antibodies in serum and saliva. Clin. Diagn. Lab. Immunol. 10:317 322.
19. Balmaseda, A., E. Sandoval, L. Pérez, et al. 1999. Application of molecular typing techniques in the 1998 dengue epidemic in Nicaragua. Am. J. Trop. Med. Hyg. 61:893 897.
20. Balmaseda, A., S. Hammond, L. Pérez, et al. 2006. Serotype-specific differences in clinical manifestations of dengue. Am. J. Trop. Med. Hyg. 74:449 456.
21. Balmaseda, A., S.N. Hammond, M.A. Perez, et al. 2005. Assessment of the World Health Organization scheme for classification of dengue severity in Nicaragua. Am. J. Trop. Med. Hyg. 73:1059 1062.
22. Harris, E., L. Perez, C. Phares, et al. 2003. Fluid intake and decreased risk for hospitalization for dengue fever, Nicaragua. Emerg. Infect. Dis. 9:1003 1006.
23. Hammond, S.N., A. Balmaseda, L. Perez, et al. 2005. Differences in dengue severity in infants, children, and adults in a three-year hospital-based study in Nicaragua. Am. J. Trop. Med. Hyg. 73:1063 1070.
24. Colbert, J., A.L. Gordon, R. Roxelin, et al. 2007. Ultrasound measurement of gallbladder wall thickening as a diagnostic test and prognostic indicator for severe dengue in pediatric patients. Pediatr. Infect. Dis. J. 26:850 852.
25. Harris, E., E. Videa, L. Perez, et al. 2000. Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua. Am. J. Trop. Med. Hyg. 63:5 11.
26. Balmaseda, A., S.N. Hammond, Y. Tellez, et al. 2006. High seroprevalence of antibodies against dengue virus in a prospective study of schoolchildren in Managua, Nicaragua. Trop. Med. Int. Health. 11:935 942.
27. Avilés, W., O. Ortega, G. Kuan, et al. 2007. Integration of information technologies in clinical studies in Nicaragua. PLoS Med. 4:1578 1583.
28. UN. Millennium Project, Interim Report of Task Force 4 on Child and Maternal Mortality, 2002.
29. WHO. 2006. Immunization Profile - Nicaragua. Available at:http://www.who.int/vaccines/globalsummary/immunization/countryprofileresult. cfm?C="nic".